Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
出版年份 2023 全文链接
标题
Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
作者
关键词
-
出版物
BIOFACTORS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-01-14
DOI
10.1002/biof.1936
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A mechanistic review on immunomodulatory effects of selective type two cannabinoid receptor β‐caryophyllene
- (2022) Vafa Baradaran Rahimi et al. BIOFACTORS
- Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer’s Disease
- (2021) Hesam Khodadadi et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization
- (2021) Peter T. Doohan et al. AAPS Journal
- The effects of hydro-ethanolic extract of Capparis spinosa (C. spinosa) on lipopolysaccharide (LPS)-induced inflammation and cognitive impairment: Evidence from in vivo and in vitro studies
- (2020) Vafa Baradaran Rahimi et al. JOURNAL OF ETHNOPHARMACOLOGY
- Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease
- (2020) Stephanie Martins de Faria et al. JOURNAL OF PSYCHOPHARMACOLOGY
- CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation
- (2020) James M. Nichols et al. Journal of Neuroimmune Pharmacology
- Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ1-42 peptide in rat hippocampal neurons
- (2020) Zubeyir Elmazoglu et al. NEUROCHEMISTRY INTERNATIONAL
- Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis
- (2020) Carmen Navarrete et al. CURRENT HYPERTENSION REPORTS
- A Critical Review of the Role of the Cannabinoid Compounds Δ9-Tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
- (2020) Éamon Jones et al. MOLECULES
- Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
- (2019) Raquel Guerrero-Alba et al. Frontiers in Pharmacology
- The protective effects of β-caryophyllene on LPS-induced primary microglia M1/M2 imbalance: A mechanistic evaluation
- (2019) Vahid Reza Askari et al. LIFE SCIENCES
- Concordance for Parkinson's disease in twins: A 20-year update
- (2019) Samuel M. Goldman et al. ANNALS OF NEUROLOGY
- Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
- (2019) Zinah Z. Al-Ghezi et al. BRAIN BEHAVIOR AND IMMUNITY
- Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis
- (2019) Ting Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Parkinson disease
- (2019) R. Balestrino et al. EUROPEAN JOURNAL OF NEUROLOGY
- Combination of Imipramine, a sphingomyelinase inhibitor, and β-caryophyllene improve their therapeutic effects on experimental autoimmune encephalomyelitis (EAE)
- (2019) Vahid Reza Askari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cannabinoids and the expanded endocannabinoid system in neurological disorders
- (2019) Luigia Cristino et al. Nature Reviews Neurology
- The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews
- (2018) Suzanne Nielsen et al. Current Neurology and Neuroscience Reports
- Cannabinoids for Treatment of MS Symptoms: State of the Evidence
- (2018) Jessica Rice et al. Current Neurology and Neuroscience Reports
- Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis
- (2018) M. Sorosina et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
- (2018) Andrea Manterola et al. BIOCHEMICAL PHARMACOLOGY
- CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
- (2018) Maria J. Casarejos et al. JOURNAL OF ALZHEIMERS DISEASE
- The Potential Therapeutic Effects of THC on Alzheimer's Disease
- (2018) Chuanhai Cao et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- New approaches and challenges to targeting the endocannabinoid system
- (2018) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- Promising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study
- (2018) Vahid Reza Askari et al. BIOCHEMICAL PHARMACOLOGY
- The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia
- (2018) M. Mecha et al. BRAIN BEHAVIOR AND IMMUNITY
- The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
- (2017) Abhinav Anand et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis
- (2017) Coral González-García et al. EXPERIMENTAL NEUROLOGY
- Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling
- (2017) Talita A. Vrechi et al. NEUROTOXICITY RESEARCH
- Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats
- (2017) Noor Azuin Suliman et al. NEUROTOXICITY RESEARCH
- Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation
- (2017) Sabrina Giacoppo et al. Multiple Sclerosis and Related Disorders
- Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex®
- (2016) A. Carotenuto et al. ACTA NEUROLOGICA SCANDINAVICA
- How strong is the evidence that Parkinsonʼs disease is a prion disorder?
- (2016) Patrik Brundin et al. CURRENT OPINION IN NEUROLOGY
- Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study
- (2016) Assaf Shelef et al. JOURNAL OF ALZHEIMERS DISEASE
- Epidemiology of Parkinson Disease
- (2016) Andrea Lee et al. NEUROLOGIC CLINICS
- Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis
- (2016) Nicola S. Orefice et al. Neurotherapeutics
- Endocannabinoids drive the acquisition of an alternative phenotype in microglia
- (2015) M. Mecha et al. BRAIN BEHAVIOR AND IMMUNITY
- Medicinal chemistry of cannabinoids
- (2015) V Kiran Vemuri et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study
- (2015) Maria Trojano et al. EUROPEAN NEUROLOGY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
- (2015) Rea Pihlaja et al. Journal of Neuroinflammation
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
- (2015) A. Rahimi et al. NEUROSCIENCE
- Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial
- (2015) Dana Turcotte et al. PAIN MEDICINE
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
- (2015) Margherita Russo et al. NEURAL PLASTICITY
- The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors
- (2015) Miguel Moreno-Martet et al. Multiple Sclerosis and Related Disorders
- Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Sex differences in Parkinson’s disease
- (2014) Glenda E. Gillies et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms
- (2013) Matthew R. Woodward et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling
- (2013) Rongqing Chen et al. CELL
- Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
- (2013) Emelie Janefjord et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis
- (2013) Rachel Jawahar et al. DRUGS
- Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
- (2013) Slava Rom et al. Journal of Neuroimmune Pharmacology
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
- (2013) Corbin Bachmeier et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Nonmotor Symptoms in Parkinson's Disease
- (2013) Victor W. Sung et al. NEUROLOGIC CLINICS
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation
- (2013) András Iring et al. PLoS One
- CB1 Cannabinoid Receptor Activation Rescues Amyloid ß-Induced Alterations in Behaviour and Intrinsic Electrophysiological Properties of Rat Hippocampal CA1 Pyramidal Neurones
- (2012) Masoud Haghani et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Endocannabinoid, Anandamide, Augments Notch-1 Signaling in Cultured Cortical Neurons Exposed to Amyloid-β and in the Cortex of Aged Rats
- (2012) Riffat Tanveer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
- (2012) Koichi Wakabayashi et al. MOLECULAR NEUROBIOLOGY
- CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients
- (2012) Maite Solas et al. NEUROBIOLOGY OF AGING
- Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
- (2012) Jiang Wu et al. NEUROBIOLOGY OF AGING
- WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
- (2012) Gohar Fakhfouri et al. NEUROPHARMACOLOGY
- Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro
- (2012) Benjamin S. Harvey et al. NEUROTOXICOLOGY
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- (2012) R. G. Pertwee PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures
- (2012) Rudolf Moldzio et al. PHYTOMEDICINE
- A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease
- (2012) Justin R. Piro et al. Cell Reports
- Current and future treatments for Alzheimer’s disease
- (2012) Konstantina G. Yiannopoulou et al. Therapeutic Advances in Neurological Disorders
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroprotective agents: Cannabinoids
- (2011) A.J. Sánchez et al. CLINICAL IMMUNOLOGY
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
- (2011) Sreemanti Basu et al. IMMUNOLOGIC RESEARCH
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults
- (2011) X. Chen et al. NEUROSCIENCE
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
- (2011) D. K. Nomura et al. SCIENCE
- Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
- (2010) Patricia Reggio CURRENT MEDICINAL CHEMISTRY
- Alzheimer Disease
- (2010) Rudy J. Castellani et al. DM DISEASE-A-MONTH
- Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
- (2010) Matthias Karst et al. DRUGS
- Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons
- (2010) Janis Noonan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Pathologic Cascade Leading to Synaptic Dysfunction in -Synuclein-Induced Neurodegeneration
- (2010) D. A. Scott et al. JOURNAL OF NEUROSCIENCE
- Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
- (2010) RBC Kavia et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- An introduction to the endocannabinoid system: from the early to the latest concepts
- (2009) Luciano De Petrocellis et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
- (2009) Shaheen E Lakhan et al. BMC Neurology
- The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
- (2009) Rosa María Tolón et al. BRAIN RESEARCH
- Cannabinoids as novel anti-inflammatory drugs
- (2009) Prakash Nagarkatti et al. Future Medicinal Chemistry
- Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
- (2009) Jeremy Koppel et al. Lipids in Health and Disease
- Adverse effects of medical cannabinoids: a systematic review
- (2008) T. Wang et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cannabinoid Receptors: Where They are and What They do
- (2008) K. Mackie JOURNAL OF NEUROENDOCRINOLOGY
- CB2receptors in the brain: role in central immune function
- (2007) G A Cabral et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB2receptor-mediated migration of immune cells: it can go either way
- (2007) A M Miller et al. BRITISH JOURNAL OF PHARMACOLOGY
- In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
- (2006) B B Yao et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started